期刊
BLOOD
卷 124, 期 11, 页码 E11-E20出版社
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2014-04-572958
关键词
-
类别
资金
- Cancer Research UK
- Leukaemia and Lymphoma Research Foundation
- Biotechnology and Biological Sciences Research Council
- BBSRC [BB/F000499/1, BB/I001220/1, BB/I001220/2, BB/I001794/1] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/I001794/1, BB/I001220/1, BB/I001220/2, BB/F000499/1] Funding Source: researchfish
- Cancer Research UK [12487, 15675, 12486] Funding Source: researchfish
During ontogeny, the transcription factor RUNX1 governs the emergence of definitive hematopoietic cells from specialized endothelial cells called hemogenic endothelium (HE). The ultimate consequence of this endothelial-to-hematopoietic transition is the concomitant activation of the hematopoietic program and downregulation of the endothelial program. However, due to the rare and transient nature of the HE, little is known about the initial role of RUNX1 within this population. We, therefore, developed and implemented a highly sensitive DNA adenine methyltransferase identification-based methodology, including a novel data analysis pipeline, to map early RUNX1 transcriptional targets in HE cells. This novel transcription factor binding site identification protocol should be widely applicable to other low abundance cell types and factors. Integration of the RUNX1 binding profile with gene expression data revealed an unexpected early role for RUNX1 as a positive regulator of cell adhesion-and migration-associated genes within the HE. This suggests that RUNX1 orchestrates HE cell positioning and integration prior to the release of hematopoietic cells. Overall, our genome-wide analysis of the RUNX1 binding and transcriptional profile in the HE provides a novel comprehensive resource of target genes that will facilitate the precise dissection of the role of RUNX1 in early blood development.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据